https://www.pharmanow.live/latest-news/granules-india-gagillapur-usfda-inspection-11-observations 2026-10-31T22:06:08+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Granules India Completes USFDA Inspection at Gagillapur with 11 Observations Issued Granules https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f12b6893-e080-4b24-bffc-537a1f942ff9/083fe18a-4053-415a-a0fa-3a4a517becff.png https://www.pharmanow.live/latest-news/zydus-appoints-christoph-stoller-president-international-markets 2026-10-31T22:05:29+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Zydus Appoints Christoph Stoller as President and Business Unit Head for International Markets Zydus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/f12b6893-e080-4b24-bffc-537a1f942ff9/9253a3cf-3d87-4354-9ecc-752f83e7af22.png https://www.pharmanow.live/latest-news/alembic-pharmaceuticals-usfda-final-approval-venetoclax-tablets-cll-sll 2026-10-31T22:06:38+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Alembic Pharmaceuticals Gains USFDA Final Approval for Venetoclax Tablets in CLL/SLL Alembic https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/afdc48c5-342d-4f17-a1fa-874e110fd602/d1a21344-4c4c-4c8b-99be-7afa508dd355.png https://www.pharmanow.live/latest-news/sun-pharma-fda-approval-ilumya-sbla-psoriatic-arthritis 2026-10-31T22:08:00+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 Sun Pharma Gains FDA Approval for ILUMYA Expansion into Psoriatic Arthritis Indication Sun https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/afdc48c5-342d-4f17-a1fa-874e110fd602/42b8936d-808a-474a-a390-09882d31cd52.png https://www.pharmanow.live/latest-news/fda-digital-biomarker-validation-projects-als-cmt-huntingtons-disease 2026-10-31T22:09:47+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 FDA Funds Digital Biomarker Validation Projects Targeting Wearable Endpoints FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8c8edfeb-63e7-4d29-adfb-fca66038f268/9ec6753d-d4a0-442a-b7c0-ca12f76c807c.png https://www.pharmanow.live/latest-news/fda-approves-voceryq-first-plasmid-dna-immunotherapy-rrp 2026-10-31T22:12:02+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 FDA Grants Accelerated Approval for Voceryq, First Plasmid DNA-Based Immunotherapy FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8c8edfeb-63e7-4d29-adfb-fca66038f268/9e455b24-7a29-4672-8d65-7bd81ff97300.png https://www.pharmanow.live/latest-news/fda-updates-minocycline-susceptibility-breakpoints-stenotrophomonas-maltophilia 2026-10-31T22:18:33+05:30 Pharma Now en 2026-10-31T00:00:00+05:30 FDA Updates Minocycline Susceptibility Breakpoints for Stenotrophomonas maltophilia Labeling Alignment FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d39ac6f8-5e27-4f8b-84cf-e692be53425f/02a0b14b-37aa-4c07-997a-f8ca13be58f0.png https://www.pharmanow.live/latest-news/viatris-tender-offer-acquire-pacira-biosciences 2026-10-31T11:30:44+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 Viatris Launches $1.65B Tender Offer for Pacira BioSciences Viatris https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://newsroom.viatris.com/file.php/181193/Refreshed_Viatris_Logo_thumb.png?thumbnail=144 https://www.pharmanow.live/latest-news/ema-prac-immunoglobulin-hypersensitivity-batch-review-2026 2026-10-31T11:27:50+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 EMA PRAC Opens Class-Wide Review of Human Immunoglobulin Safety EMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ema-prac-human-normal-immunoglobulin-batch-hypersensitivity-review-202620261031112743.webp https://www.pharmanow.live/latest-news/fda-risk-based-inspection-model-cgmp-compliance-drug-manufacturing 2026-10-31T11:18:48+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 FDA Reinforces Risk-Based Inspections Across U.S. Drug Plants FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/68750825-0b20-441b-a564-e1242f5a1283/3bc53589-71de-4e87-b905-c357be4f6c6f.png https://www.pharmanow.live/latest-news/fda-frame-amtdp-continuous-manufacturing-ai-regulatory-framework 2026-10-31T11:08:55+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 FDA Advances FRAME and AMTDP for AI-Driven Drug Manufacturing FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-frame-amtdp-continuous-ai-drug-manufacturing-regulatory-framework-202620261031110739.webp https://www.pharmanow.live/latest-news/celularity-vesalius-longevity-labs-exclusive-peptide-api-manufacturing-deal 2026-10-31T10:47:42+05:30 Pharma Now en 2026-10-30T00:00:00+05:30 Celularity Signs Exclusive Deal with Vesalius Longevity Labs Celularity https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/celularity-vesalius-exclusive-peptual-peptide-api-manufacturing-deal-202620261031104315.webp